Results for this period
Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Net sales increased due to the full-year contribution from Mediplat and フィッツプラス and organic growth in existing businesses. Operating profit declined as expenses increased due to changes in the sales mix, higher personnel expenses, higher software amortization associated with systems investments, upfront investments in new businesses and one-time expenses.
No matters applicable. “None applicable.”
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥9,923 million (YoY +16.0%) |
| Operating profit | ¥997 million (YoY -2.5%) |
| Ordinary income | ¥1,003 million (YoY -2.0%) |
| Profit attributable to owners of the parent | ¥686 million (YoY -7.8%) |
| Net income per share | ¥43.73 |
| Operating Margin | 10.1% |
| Equity ratio | End of the current fiscal period 50.4% / End of previous period 44.8% |
| Total assets | ¥8,580 million |
| Net assets | ¥4,379 million |
| Cash flows from operating activities | ¥1,926 million |
| Cash flows from investing activities | ¥-1,062 million |
| Cash flows from financing activities | ¥-750 million |
| Cash and cash equivalents at end of period | ¥1,838 million |
| Full-year earnings forecast | Net Sales ¥10,700 million (YoY +7.8%) / Operating profit ¥1,240 million (YoY +24.3%) / Ordinary income ¥1,240 million (YoY +23.5%) / Net income ¥844 million (YoY +22.9%) |
| Annual Dividend Forecast | ¥17 → ¥19（+11.8%） |
| Payout ratio | 38.9% (35.4% forecast for the fiscal year ending March 2027) |
| Shareholder Return Policy | Continuously pay stable dividends, with a consolidated payout ratio of at least 35% as a guideline |
| Segment revenue | Mentality Management business ¥7,632,379 thousand (YoY +17.4%), Employment Support for People with Disabilities Business ¥1,724,782 thousand (YoY -0.1%), Risk Financing Business ¥339,352 thousand (YoY +3.8%), Small-Amount and Short-Term Insurance Business ¥227,237 thousand |
| Segment profit | Mentality Management business ¥1,242,612 thousand (YoY +15.5%), Employment Support for People with Disabilities Business ¥414,294 thousand (YoY -17.7%), Risk Financing Business ¥220,140 thousand (YoY -5.1%), Small-Amount and Short-Term Insurance Business ¥-37,625 thousand |
| Depreciation and amortization | ¥993,016 thousand |
| Impairment loss | ¥0 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Subsidy Income ¥20,000 thousand / Extraordinary loss Loss on Disposal of Fixed Assets ¥96 thousand, Loss on reduction of fixed assets ¥14,901 thousand |
| Disclosure regarding the going concern assumption | No matters applicable. “None applicable.” |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate Yes / Restatement No |
| Changes in the scope of consolidation | New Number of companies 1 / Company name 健康年齢少額短期保険株式会社 / Excluded Number of companies 1 / Company name ここむ株式会社 |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Held (対象者：Not disclosed) |
| Issued Shares at Period-End | 16,280,200 shares |
| Treasury Shares at Period-End | 576,654 shares |
| Factors Behind Changes in Business Performance | Net sales increased due to the full-year contribution from Mediplat and フィッツプラス and organic growth in existing businesses. Operating profit declined as expenses increased due to changes in the sales mix, higher personnel expenses, higher software amortization associated with systems investments, upfront investments in new businesses and one-time expenses. |
Items this document does not state (3)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Net sales increased due to the full-year contribution from Mediplat Co., Ltd. and フィッツプラス株式会社, which became subsidiaries in the previous fiscal year, as well as continued solid organic growth in existing businesses. Profit was affected by higher expenses resulting from changes in the sales mix, increased personnel expenses accompanying employee wage increases, higher software amortization from systems investments based on the growth strategy, upfront investments in new businesses and one-time expenses incurred during the fiscal year.